ORIC Pharmaceuticals advances rinzimetostat into the global Phase 3 Himalayas-1 trial for mCRPC, with full global rights.
BACKGROUND: Metabolic adaptation and maladaptation are hallmarks of the failing heart and may be a target for therapeutic ...
Your institution does not have access to this book on JSTOR. Try searching on JSTOR for other items related to this book. https://doi.org/10.2307/j.ctv1131bk8.4 https ...
Chemical castration of sex offenders will be trialled in northern England, David Lammy announced. The Justice Secretary informed MPs that a pilot scheme in south-west England had yielded "positive" ...
360 With Jillian 360 With Jillian is a long-form conversation series with your favorite musicians, actors, and celebrities that explores their never-before-heard stories and the keys to success in an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results